CHRISTOPHER LINKE: Open Payments
NPI 1639571656 · GRAND ISLAND, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,806 in 108 payments from 17 companies in 2025. Trend: 2023 $1,854 · 2024 $1,676 · 2025 $1,806
Food & beverage: $1,714Education: $92
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $422 |
| UCB, Inc. | 12 | $219 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 7 | $206 |
| Lilly USA, LLC | 14 | $185 |
| Janssen Biotech, Inc. | 9 | $144 |
| E.R. Squibb & Sons, L.L.C. | 16 | $135 |
| Novartis Pharmaceuticals Corporation | 5 | $97 |
| GENZYME CORPORATION | 5 | $78 |
| LEO Pharma Inc. | 3 | $69 |
| Regeneron Healthcare Solutions, Inc. | 2 | $66 |
Products named: SKYRIZI, Bimzelx, TALTZ, RINVOQ, TREMFYA, DUPIXENT, Sotyktu, ILUMYA.
Industry payments across NE — which companies pay providers there.
